pipette
ESEspañol

Human antibody combinations determined by epitope mapping of orthopoxvirus A33/A35 confer therapeutic protection in mice

Anqi Xia, Qiwei Jiang, Xiaojie Wang, Jie Liu, Jiannan Chen, Haozhe Zhao, Siyuan Sun, Wei Wu, Weiyu Jiang, Song Xue, Yi-ou Sha, Yingying Song, Qianqian Zhang, Yaming Li, Liyuan Hu, Haiyu Wang, Yiming Long, Yidan Gao, Yuru Han, Jieliang Chen, Cong Zeng, Lu Lu, Rong Zhang, Rong Xia, Zhenghong Yuan, Xiao Li, Yixiao Zhang, Qiao Wang

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Combinations of mAbs targeting nonoverlapping epitopes mediated synergistic, Fc-dependent neutralization in vitro; conferred therapeutic protection against lethal VACV challenge; and reduced viral burden and disease severity after MPXV challenge in mice.

Appeared: Friday, November 13. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.aeb2836